Varaico: Literature-Extracted Genetic Variants

Gene:CACNA1C
Variant:p.A39V
Back to variants list

CACNA1C

NM_000719.7:p.A39V

Associated Papers

Timothy Syndrome and CACNA1C-Related Disorder: First International Language and Management Guidelines Consensus Statement.

Underwood JFG et al.

Research Square, 2025

Biphasic effects on human atrial arrhythmogenicity of L-type calcium channel mutations associated with a Brugada/Short QT overlap syndrome - insights from a multiscale simulation study.

Xiang Y et al.

Plos Computational Biology, 2025

Computational analysis of congenital heart disease associated SNPs: unveiling their impact on the gene regulatory system.

Vashisht S et al.

Bmc Genomics, 2025

39838281 (PubMed )
Supplement: 12864_2025_11232_MOESM4_ESM.xlsx › ClinVar_CHD-SNPs_uniq

Interpreting the actionable clinical role of rare variants associated with short QT syndrome.

Martínez-Barrios E et al.

Human Genetics, 2024

Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome.

Zhao Z et al.

Ebiomedicine, 2024

Functional identification of hot-spot mutations in cardiac calcium channel genes associated with the J wave syndromes.

Zeng B et al.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 2023

Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome.

Hancox JC et al.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 2023

Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.

Keefe JA et al.

Archives of Toxicology, 2023

Preclinical short QT syndrome models: studying the phenotype and drug-screening.

Fan X et al.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 2022

Identification of ultra-rare disruptive variants in voltage-gated calcium channel-encoding genes in Japanese samples of schizophrenia and autism spectrum disorder.

Wang C et al.

Translational Psychiatry, 2022

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening.

El-Battrawy I et al.

Clinical and Translational Medicine, 2021

34954893 (PubMed )
Supplement: CTM2-11-e646-s006.DOC

L-Type Calcium Channel: Predicting Pathogenic/Likely Pathogenic Status for Variants of Uncertain Clinical Significance.

Tarnovskaya SI et al.

Membranes, 2021

Clinical and Functional Genetic Characterization of the Role of Cardiac Calcium Channel Variants in the Early Repolarization Syndrome.

Chen X et al.

Frontiers in Cardiovascular Medicine, 2021

Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome.

Marcantoni A et al.

Pflugers Archiv : European Journal of Physiology, 2020

Short QT Syndrome: A Comprehensive Genetic Interpretation and Clinical Translation of Rare Variants.

Campuzano O et al.

Journal of Clinical Medicine, 2019

A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel.

Ye D et al.

Heart Rhythm, 2019

Penetrance and expressivity of the R858H CACNA1C variant in a five-generation pedigree segregating an arrhythmogenic channelopathy.

Gardner RJM et al.

Molecular Genetics & Genomic Medicine, 2019

Expanding clinical phenotype in CACNA1C related disorders: From neonatal onset severe epileptic encephalopathy to late-onset epilepsy.

Bozarth X et al.

American Journal of Medical Genetics. Part A, 2018

An African loss-of-function CACNA1C variant p.T1787M associated with a risk of ventricular fibrillation.

Blancard M et al.

Scientific Reports, 2018

Emerging therapeutic targets in the short QT syndrome.

Hancox JC et al.

Expert Opinion on Therapeutic Targets, 2018

Mutations in voltage-gated L-type calcium channel: implications in cardiac arrhythmia.

Zhang Q et al.

Channels (austin, Tex.), 2018

The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome.

Hu D et al.

Jacc. Clinical Electrophysiology, 2017

Brugada syndrome: a fatal disease with complex genetic etiologies - still a long way to go.

Wu Y et al.

Forensic Sciences Research, 2017

[Brugada syndrome--a rare cause of syncope and sudden death].

Levin CG et al.

Lakartidningen, 2015

Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.

Wemhöner K et al.

Journal of Molecular and Cellular Cardiology, 2015

Calcium Channel Mutations in Cardiac Arrhythmia Syndromes.

Betzenhauser MJ et al.

Current Molecular Pharmacology, 2015

Short QT Syndrome - Review of Diagnosis and Treatment.

Rudic B et al.

Arrhythmia & Electrophysiology Review, 2014

Effect of the Brugada syndrome mutation A39V on calmodulin regulation of Cav1.2 channels.

Simms BA et al.

Molecular Brain, 2014

Genetics of bipolar disorder.

Kerner B

The Application of Clinical Genetics, 2014

Channelopathy pathogenesis in autism spectrum disorders.

Schmunk G et al.

Frontiers in Genetics, 2013

β-blockers in congenital short-QT syndrome as ion channel blockers.

Abriel H et al.

Journal of Cardiovascular Electrophysiology, 2013

Arrhythmogenesis in Brugada syndrome: impact and constrains of current concepts.

Bébarová M

International Journal of Cardiology, 2013

What can naturally occurring mutations tell us about Ca(v)1.x channel function?

Stockner T et al.

Biochimica Et Biophysica Acta, 2013

Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome.

Boczek NJ et al.

Circulation. Cardiovascular Genetics, 2013

Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy.

Pérez Riera AR et al.

Cardiology Journal, 2013

The genetic component of Brugada syndrome.

Nielsen MW et al.

Frontiers in Physiology, 2013

Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation.

Hong K et al.

European Journal of Human Genetics : Ejhg, 2012

Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Venetucci L et al.

Nature Reviews. Cardiology, 2012

Arrhythmia-associated cardiac Ca²(+) cycling proteins and gene mutations.

Kochhäuser S et al.

Wiener Medizinische Wochenschrift (1946), 2012

The Brugada syndrome mutation A39V does not affect surface expression of neuronal rat Cav1.2 channels.

Simms BA et al.

Molecular Brain, 2012

Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels.

Bidaud I et al.

Biochimie, 2011

Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel.

Napolitano C et al.

Circulation Research, 2011

Short QT syndrome: from bench to bedside.

Patel C et al.

Circulation. Arrhythmia and Electrophysiology, 2010

Absence of calcium channel alpha1C-subunit mutation in human atrial fibrillation.

Soon JL et al.

Asian Cardiovascular & Thoracic Annals, 2010

1–50 of 60 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."